Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Stenham Launches New Credit and Healthcare Funds

Stenham Asset Management, the multi-award winning investment management firm, has recently launched a new Credit and a new Healthcare fund of hedge funds – Stenham Credit Opportunities and Stenham Healthcare.

Stenham Credit Opportunities launched on 1 January 2013 with US$ 21 million and has returned 3.44% since inception. The fund is a concentrated portfolio of credit managers, targeting 8-12% annualised returns and allocates across the full spectrum of credit strategies, investing in best-in-class managers in credit long/short, structured credit and distressed debt strategies which are often unavailable to traditional investors. Allocations to individual strategies are managed dynamically as opportunity sets evolve. The fund invests in 6-10 high conviction managers and offers quarterly liquidity with 95 days’ notice. The fund has a 25% gate.

Stenham Healthcare also launched on 1 January 2013 with US$ 15 million and has returned 7.48% since inception. The fund is a concentrated portfolio of managers focused on the healthcare sector, targeting double digit annualised returns. The fund invests in primarily equity based healthcare strategies with around 6-10 managers with proven track records. The fund attempts to give investors exposure to the healthcare sector via experienced specialist healthcare managers and offers monthly liquidity with 35 days’ notice.

Stenham has been invested in Credit and Healthcare strategies for over 20 years as part of other portfolios the firm manages. It has launched the two stand-alone funds in response to increasing investor demand for niche, focused funds of hedge funds.

Tim Beck, Senior Research Analyst and Fund Lead for Stenham Credit Opportunities said: ‘We launched Stenham Credit Opportunities as a stand-alone credit-focused fund as we saw compelling opportunities in the market. Credit markets tend to be structurally inefficient with many investors prohibited from holding certain assets e.g. defaulted debt. Our portfolio invests in three key areas: Credit Long/Short; Structured Credit; and Distressed Debt. The fund is focused on managers who can actively short and benefit from the asymmetry in credit; the fund will take more directional exposure in structured credit and selected distressed investments, including liquidations as well as opportunities from bank deleveraging’.

He added: ‘Many investors are wary of investing in on-the-run credit and fixed income securities given current yields. We believe the greater breadth of investments offered through this product, coupled with funds actively shorting segments of the market offers a compelling investment alternative’.

Dominique Montier, Senior Executive and Fund Lead for Stenham Healthcare said: ‘The Healthcare sector provides a compelling story offering both growth and defensive characteristics. Both demographic changes such as an aging population and the emerging middle class in developing markets are contributing to long-term structural growth for the sector. From a valuation perspective, valuations are still at historically low levels. Our portfolio attempts to combine specialist healthcare managers with complementary skills in a way that should provide outsized returns and reduced volatility relative to the overall healthcare indices’.

Stenham has broadened its range of funds in recent years with the launch of Stenham Helix, a global macro fund of hedge funds with 35 day liquidity, in January 2012; and Stenham Emerging Markets, a long biased fund of funds, in September 2012. The firm has 13 funds in total variously focused on Multi Strategy, Global Macro, Equity Biased, Credit and Commodity strategies.